醫揚 6569
OTC · Biotechnology and medical care77.2▼-2.4 (-3.02%)After close
- Prev close
- 79.6
- Volume (shares)
- 35,000
- Data time
- 2026-11-12 13:30:00
- Open
- 79.80
- High
- 79.80
- Low
- 77.10
- Prev close
- 79.60
- Volume (lots)
- 35
- Turnover
- 0.03 億
- P/E
- 19.5
- Cash yield
- 3.89%
Financial trends
Loading…
Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.
Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC
Loading…
Figures are shown as announced, with no scoring or rating.
| Metric | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 26.63% | 28.90% | 36.13% | 37.10% | 30.19% | 34.88% | 29.85% | 38.77% |
| Operating margin | -6.69% | 3.91% | 7.84% | 8.66% | -0.33% | 9.12% | -2.14% | 14.81% |
| Net margin | 6.21% | 14.62% | 10.68% | 14.73% | 10.20% | 6.76% | 2.37% | 16.94% |
| ROE (TTM) | 9.88% | 12.09% | 9.07% | 7.20% | 8.71% | 8.39% | 8.68% | 11.84% |
| ROA (TTM) | 7.53% | 8.07% | 6.60% | 5.24% | 6.17% | 5.58% | 6.37% | 8.67% |
| EPS, quarter (TWD) | 0.44 | 1.61 | 1.03 | 1.19 | 0.88 | 0.62 | 0.19 | 1.68 |
| EPS, TTM (TWD) | 4.27 | 4.71 | 3.72 | 2.88 | 3.37 | 3.16 | 3.36 | 4.69 |
| Month | Revenue | MoM | YoY | YTD | YTD YoY |
|---|---|---|---|---|---|
| 2026-10 | 0.8 | -31.93% | -9.48% | 12.0 | 10.32% |
| 2026-09 | 1.2 | -9.94% | -2.13% | 11.2 | 12.14% |
| 2026-08 | 1.4 | 146.10% | 43.20% | 10.0 | 14.17% |
| 2026-07 | 0.5 | -65.90% | -50.55% | 8.6 | 10.65% |
| 2026-06 | 1.6 | -5.93% | 17.04% | 8.1 | 20.85% |
| 2026-05 | 1.7 | 77.37% | 49.78% | 6.5 | 21.84% |
| 2026-04 | 1.0 | -50.27% | -8.28% | 4.7 | 14.14% |
| 2026-03 | 1.9 | 84.94% | 49.18% | 3.8 | 21.76% |
| 2026-02 | 1.1 | 34.63% | 7.70% | 1.8 | 1.88% |
| 2026-01 | 0.8 | -39.12% | -5.02% | 0.8 | -5.02% |
| 2025-12 | 1.3 | 33.61% | -24.06% | 13.1 | 5.80% |
| 2025-11 | 1.0 | 4.69% | -7.63% | 11.9 | 10.50% |
Revenue in NT$100M; 12 months per page.
| Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.1 | 4.3 | 3.8 | 3.2 | 3.3 | 3.6 | 3.1 | 3.8 |
| Cost of revenue | 2.3 | 3.1 | 2.4 | 2.0 | 2.3 | 2.3 | 2.2 | 2.3 |
| Gross profit | 0.8 | 1.2 | 1.4 | 1.2 | 1.0 | 1.2 | 0.9 | 1.5 |
| Operating expenses | 1.0 | 1.1 | 1.1 | 0.9 | 1.0 | 0.9 | 1.0 | 0.9 |
| Operating income | -0.2 | 0.2 | 0.3 | 0.3 | -0.0 | 0.3 | -0.1 | 0.6 |
| Non-operating items | 0.4 | 0.5 | 0.2 | 0.2 | 0.4 | -0.1 | 0.1 | 0.2 |
| Pre-tax income | 0.2 | 0.7 | 0.5 | 0.5 | 0.4 | 0.3 | 0.1 | 0.8 |
| Income tax | -0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | -0.0 | 0.1 |
| Continuing operations | 0.2 | 0.6 | 0.4 | 0.5 | 0.3 | 0.2 | 0.1 | 0.6 |
| Net income | 0.2 | 0.6 | 0.4 | 0.5 | 0.3 | 0.2 | 0.1 | 0.6 |
| Net income to parent | 0.2 | 0.6 | 0.4 | 0.5 | 0.3 | 0.2 | 0.1 | 0.6 |
| Net income to NCI | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | -0.0 | -0.0 |
| Other comprehensive income | -0.0 | -0.1 | -0.1 | 0.0 | -0.0 | 0.2 | 0.1 | 0.0 |
| Total comprehensive income | 0.1 | 0.6 | 0.3 | 0.5 | 0.3 | 0.4 | 0.2 | 0.7 |
| EPS (TWD) | 0.44 | 1.61 | 1.03 | 1.19 | 0.88 | 0.62 | 0.19 | 1.68 |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Current assets | 9.2 | 9.8 | 8.8 | 8.3 | 8.1 | 8.8 | 8.1 | 8.2 |
| Non-current assets | 14.5 | 13.8 | 14.0 | 13.2 | 13.1 | 13.0 | 13.0 | 12.8 |
| Total assets | 23.7 | 23.6 | 22.8 | 21.5 | 21.2 | 21.7 | 21.1 | 21.1 |
| Current liabilities | 2.8 | 6.1 | 4.8 | 3.8 | 3.9 | 4.7 | 2.9 | 3.4 |
| Non-current liabilities | 1.9 | 2.0 | 2.0 | 2.0 | 2.1 | 2.1 | 2.1 | 2.1 |
| Total liabilities | 4.7 | 8.1 | 6.8 | 5.8 | 6.0 | 6.8 | 5.0 | 5.5 |
| Share capital | 4.3 | 3.9 | 3.9 | 3.9 | 3.9 | 3.9 | 3.9 | 3.9 |
| Capital surplus | 10.5 | 7.5 | 7.6 | 7.6 | 7.6 | 7.5 | 7.5 | 7.2 |
| Retained earnings | 4.4 | 4.2 | 4.5 | 4.1 | 3.7 | 3.4 | 4.7 | 4.6 |
| Other equity | -0.1 | -0.1 | -0.0 | 0.1 | 0.0 | 0.1 | -0.1 | -0.2 |
| Equity to parent | 19.0 | 15.5 | 16.0 | 15.7 | 15.2 | 14.9 | 16.0 | 15.4 |
| Non-controlling interests | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Total equity | 19.0 | 15.5 | 16.0 | 15.7 | 15.2 | 15.0 | 16.1 | 15.5 |
| Book value per share (TWD) | 44.41 | 39.70 | 41.00 | 40.19 | 38.90 | 38.13 | 40.94 | 39.99 |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 0.6 | -0.5 | -0.8 | 0.3 | 0.7 | 0.2 | 0.4 | 0.6 |
| Investing cash flow | -0.4 | -0.1 | -0.7 | 0.0 | -0.1 | -0.1 | -0.1 | -0.0 |
| Financing cash flow | -0.2 | 0.8 | 0.2 | 0.1 | -1.1 | 0.6 | -0.5 | -0.1 |
| FX effect | 0.0 | -0.0 | 0.0 | 0.1 | 0.1 | -0.1 | 0.0 | 0.0 |
| Net change in cash | 0.0 | 0.2 | -1.4 | 0.5 | -0.5 | 0.5 | -0.1 | 0.5 |
| Cash, beginning | 3.7 | 3.7 | 3.7 | 3.2 | 3.2 | 3.2 | 3.2 | 3.7 |
| Cash, ending | 2.6 | 2.6 | 2.4 | 3.7 | 3.2 | 3.7 | 3.2 | 3.2 |
Amounts in NT$100M (per-share items in NT$).
| Metric | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Current ratio | 324.07% | 160.74% | — | — | — | — | — | — |
| Debt ratio | 19.75% | 34.41% | 29.71% | 27.10% | 28.31% | 31.21% | 23.74% | 26.28% |
| Equity ratio | 80.25% | 65.59% | 70.29% | 72.90% | 71.69% | 68.79% | 76.26% | 73.72% |
| Equity multiplier | 1.25 | 1.52 | 1.42 | 1.37 | 1.39 | 1.45 | 1.31 | 1.36 |
| Metric | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Asset turnover (TTM revenue / avg. assets) | 0.64 | 0.64 | 0.63 | 0.62 | 0.66 | 0.61 | 0.59 | 0.60 |
| Equity turnover | 0.84 | 0.95 | 0.86 | 0.84 | 0.92 | 0.90 | 0.80 | 0.81 |
Source: MOPS. For reference only; not investment advice.